跳至主要内容
临床试验/IRCT20160809029275N5
IRCT20160809029275N5已完成2 期

Evaluation of neuro-inflammatory markers for amyotrophic lateral sclerosis (ALS) patients before and after Mesenchymal Stem Cell (MSC) transplantation

Mashhad University of Medical Sciences0 个研究点目标入组 25 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 75 years(—)
性别
All

入选标准

  • Patients with ALS confirmed by a neurologist with an ALSFRS-R score between 31-46.
  • Patients must have been treated with a stable dose of Rilozule for the previous 3 months.
  • Patients should not have any other chronic diseases and should not use ventilators.
  • Patients in the age range of 18 to 75 years.

排除标准

  • Patients with malignancy.
  • Patients with other chronic diseases.
  • Suffering from other neurodegenerative diseases.
  • Simultaneous participation in other clinical trials

研究者

相似试验